Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α2-adrenoceptor: A combined randomised animal and in vitro study
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy May 2024 174 - Subject
- Language
- ISSN
- 0753-3322